Kodiak Sciences (KOD)
Develops intravitreal biologics for retinal vascular and inflammatory diseases.
$37.40
Pre-market−0.11 (−0.29%)
At close$37.51(+1.21%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
in 70 days
EPS estimate
−$0.99
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported−$1.09−$1.03−$1.16−$1.04−$0.94−$1.05−$1.05Pending
Estimate−$0.89−$1.01−$1.07−$1.02−$0.93−$0.96−$0.96−$0.99
Surprise−22.5%−2.0%−8.4%−2.0%−1.1%−9.8%−9.8%—
RevenueReportedEstimate
May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.99 | — | — |
| Aug 2026 | −$0.96 | −$1.05 | −9.8% |
| Aug 2026 | −$0.96 | −$1.05 | −9.8% |
| May 2026 | −$0.93 | −$0.94 | −1.1% |
| Mar 2026 | −$1.02 | −$1.04 | −2.0% |
The latest year is open to everyone — the 35 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Oct 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.99 | — | — | — | — | — | — |
| Aug 13, 2026 | −$0.96 | −$1.05 | −9.8% | — | — | — | +3.4% |
| Aug 12, 2026 | −$0.96 | −$1.05 | −9.8% | — | — | — | −7.9% |
| May 7, 2026 | −$0.93 | −$0.94 | −1.1% | — | — | — | −6.1% |
| Mar 31, 2026 | −$1.02 | −$1.04 | −2.0% | — | — | — | +12.3% |
The latest year is open to everyone — the 35 quarters behind it read with an account. Sign in | |||||||
| Nov 13, 2025 | |||||||
| Aug 13, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 28, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 16, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 15, 2019 | |||||||
| Mar 28, 2019 | |||||||
| Nov 16, 2018 | |||||||
| Oct 5, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||